Freenome is a health technology company bringing accurate, accessible and non-invasive disease screenings to patients and doctors to proactively treat cancer and other diseases at their most manageable stages. The company does this through a fusion of machine learning, next-generation sequencing, biology and computer science in an effort to equip people with the knowledge and tools to maintain a healthier life.
Select investors Andreessen Horowitz, Founders Fund, Third Kind Venture Capital, GV, Polaris Partners, Asset Management Ventures, Verily, Data Collective, Innovation Endeavors
Last update: April 10, 2018
Disclaimer: We can not guarantee that the information on this page is 100% correct. more